Condensed Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 29,311	$ 16,231	$ 52,511	$ 41,340
General and administrative	8,032	5,739	15,944	11,887
Total operating expenses	37,343	21,970	68,455	53,227
Loss from operations	(37,343)	(21,970)	(68,455)	(53,227)
Other income (expense):
Interest income	5,104	2,239	9,290	3,862
Interest expense	(1,912)	(914)	(3,819)	(1,789)
Other income	450	511	904	953
Change in fair value of non-marketable equity securities	(7)	(28)	(11)	(30)
Total other income	3,635	1,808	6,364	2,996
Net loss	(33,708)	(20,162)	(62,091)	(50,231)
Other comprehensive income (loss):
Change in unrealized (loss) gain on marketable securities	(277)	(138)	(700)	82
Comprehensive loss	$ (33,985)	$ (20,300)	$ (62,791)	$ (50,149)
Net loss per share attributable to common stockholders, basic	$ (0.62)	$ (0.46)	$ (1.17)	$ (1.23)
Net loss per share attributable to common stockholders, diluted	$ (0.62)	$ (0.46)	$ (1.17)	$ (1.23)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic	54,728,552	44,269,772	52,850,242	40,986,907
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	54,728,552	44,269,772	52,850,242	40,986,907